MaxCyte, Inc. Increase (Decrease) in Other Operating Liabilities
MaxCyte, Inc. (MXCT) reported Increase (Decrease) in Other Operating Liabilities of $39.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-13
- MaxCyte, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $40.00K.
- MaxCyte, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was -$1.00K.
- MaxCyte, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $11.00K.
- MaxCyte, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$21.00K.
- MaxCyte, Inc. increase (decrease) in other operating liabilities for fiscal 2025 was -$36.00K.
- MaxCyte, Inc. increase (decrease) in other operating liabilities for fiscal 2024 was -$9.00K.
- MaxCyte, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was -$39.00K, a 104.48% decline from fiscal 2022.
- MaxCyte, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was $871.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $39.00K 10-Q · filed 2026-08-13 | $50.00K derived: sum of 3 quarters · filed 2026-08-13 | $29.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$1.00K 10-Q · filed 2026-05-13 | $10.00K derived: sum of 2 quarters · filed 2026-05-13 | -$11.00K derived: sum of 3 quarters · filed 2026-05-13 | -$33.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$10.00K derived: sum of 2 quarters · filed 2026-03-25 | -$32.00K derived: sum of 3 quarters · filed 2026-08-13 | -$36.00K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$43.00K derived: sum of 2 quarters · filed 2026-08-13 | -$47.00K 10-Q · filed 2025-11-13 | -$50.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$26.00K 10-Q · filed 2026-08-13 | -$29.00K derived: sum of 3 quarters · filed 2026-08-13 | -$62.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$4.00K 10-Q · filed 2026-05-13 | -$7.00K derived: sum of 2 quarters · filed 2026-05-13 | -$40.00K derived: sum of 3 quarters · filed 2026-05-13 | -$9.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$36.00K derived: sum of 2 quarters · filed 2026-03-25 | -$5.00K derived: sum of 3 quarters · filed 2026-03-25 | -$9.00K 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.00K derived: sum of 2 quarters · filed 2025-11-13 | -$6.00K 10-Q · filed 2025-11-13 | -$42.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $27.00K 10-Q · filed 2025-08-06 | -$9.00K derived: sum of 3 quarters · filed 2025-08-06 | $1.00K derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | -$4.00K 10-Q · filed 2025-05-08 | -$40.00K derived: sum of 2 quarters · filed 2025-05-08 | -$30.00K derived: sum of 3 quarters · filed 2025-05-08 | -$30.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$26.00K derived: sum of 2 quarters · filed 2025-03-11 | -$26.00K derived: sum of 3 quarters · filed 2025-03-11 | -$39.00K 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $10.00K derived: sum of 2 quarters · filed 2024-11-06 | -$3.00K 10-Q · filed 2024-11-06 | -$3.20K 10-Q · filed 2023-11-08 | $973.60K derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$13.00K 10-Q · filed 2024-08-06 | -$13.20K 10-Q · filed 2023-08-09 | $963.60K derived: sum of 3 quarters · filed 2024-08-06 | $915.20K derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | -$13.00K 10-Q · filed 2024-05-07 | -$12.60K 10-Q · filed 2023-05-10 | $963.60K derived: sum of 2 quarters · filed 2024-05-07 | $915.20K derived: sum of 3 quarters · filed 2024-05-07 | $857.10K derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | $976.60K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $928.20K derived: sum of 2 quarters · filed 2024-03-12 | $870.10K derived: sum of 3 quarters · filed 2024-03-12 | $871.00K 10-K · filed 2024-03-12 | $871.40K 10-K · filed 2023-03-15 | |||
| 2022-09-30 | -$48.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$106.50K derived: sum of 2 quarters · filed 2023-11-08 | -$105.60K 10-Q · filed 2023-11-08 | -$152.00K derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$58.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$57.20K 10-Q · filed 2023-08-09 | -$103.60K derived: sum of 3 quarters · filed 2023-08-09 | -$168.70K derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $900.00 10-Q · filed 2023-05-10 | -$45.50K derived: sum of 2 quarters · filed 2023-05-10 | -$110.60K derived: sum of 3 quarters · filed 2023-05-10 | -$146.00K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | -$46.40K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$111.50K derived: sum of 2 quarters · filed 2023-03-15 | -$146.90K derived: sum of 3 quarters · filed 2023-03-15 | -$73.50K 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | -$65.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$100.50K derived: sum of 2 quarters · filed 2022-11-09 | -$27.10K 10-Q · filed 2022-11-09 | -$240.10K derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$35.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $38.00K 10-Q · filed 2022-08-10 | -$175.00K derived: sum of 3 quarters · filed 2022-08-10 | -$5.70K derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $73.40K 10-Q · filed 2022-05-09 | -$139.60K derived: sum of 2 quarters · filed 2022-05-09 | $29.70K derived: sum of 3 quarters · filed 2022-05-09 | |||||
| 2020-12-31 | -$213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$43.70K derived: sum of 2 quarters · filed 2022-03-22 | -$58.00K 10-K · filed 2022-03-22 | |||||
| 2020-09-30 | $169.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $155.00K 10-Q · filed 2021-11-10 | ||||||
| 2020-06-30 | -$14.30K 10-Q · filed 2021-09-13 | |||||||
| 2019-12-31 | -$655.00K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |